NGM BIOPHARMACEUTICALS INC's ticker is NGM and the CUSIP is 62921N105. A total of 60 filers reported holding NGM BIOPHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 1.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $667,455 | -67.0% | 623,790 | -20.2% | 0.00% | -100.0% |
| Q2 2023 | $2,023,663 | +64409.5% | 781,337 | +1.6% | 0.00% | 0.0% |
| Q1 2023 | $3,137 | -17.5% | 768,884 | +1.5% | 0.00% | 0.0% |
| Q4 2022 | $3,803 | -100.0% | 757,753 | +2.6% | 0.00% | -75.0% |
| Q3 2022 | $9,664,000 | +40.8% | 738,810 | +38.0% | 0.00% | +33.3% |
| Q2 2022 | $6,864,000 | +82.9% | 535,438 | +116.8% | 0.00% | +200.0% |
| Q1 2022 | $3,752,000 | -17.2% | 247,026 | -3.4% | 0.00% | 0.0% |
| Q4 2021 | $4,529,000 | +11.8% | 255,760 | +45.4% | 0.00% | 0.0% |
| Q3 2021 | $4,052,000 | +65.5% | 175,936 | +41.7% | 0.00% | 0.0% |
| Q2 2021 | $2,449,000 | -51.2% | 124,163 | -28.1% | 0.00% | -50.0% |
| Q1 2021 | $5,020,000 | +65.8% | 172,676 | +72.7% | 0.00% | +100.0% |
| Q4 2020 | $3,028,000 | +102.8% | 99,980 | +6.5% | 0.00% | 0.0% |
| Q3 2020 | $1,493,000 | -32.5% | 93,837 | -16.3% | 0.00% | 0.0% |
| Q2 2020 | $2,213,000 | +56.8% | 112,118 | -2.0% | 0.00% | 0.0% |
| Q1 2020 | $1,411,000 | -65.7% | 114,438 | -48.6% | 0.00% | -50.0% |
| Q4 2019 | $4,113,000 | +1146.4% | 222,469 | +833.4% | 0.00% | – |
| Q3 2019 | $330,000 | +124.5% | 23,834 | +138.0% | 0.00% | – |
| Q2 2019 | $147,000 | – | 10,016 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Greenspring Associates, LLC | 1,573,357 | $47,665,000 | 61.89% |
| RHO CAPITAL PARTNERS INC | 3,766,666 | $114,111,000 | 60.06% |
| Column Group LLC | 15,396,116 | $466,502,000 | 42.31% |
| Ponoi II Management, LLC | 1,298,908 | $39,357,000 | 28.68% |
| Ponoi Management, LLC | 1,298,908 | $39,357,000 | 22.52% |
| Euclidean Capital LLC | 2,083,602 | $63,133,000 | 13.36% |
| Aquilo Capital Management, LLC | 1,005,534 | $30,463,000 | 6.33% |
| Octagon Capital Advisors LP | 75,227 | $2,279,000 | 0.79% |
| Jasper Ridge Partners, L.P. | 308,750 | $9,354,000 | 0.41% |
| Point72 Asset Management, L.P. | 1,761,157 | $53,354,000 | 0.26% |